Gardere partner Randy D. Gordon, chair of the firm’s antitrust and trade regulation practice group, published an article with Law360 regarding the recent recasting of the proposed Walgreens-Rite Aid merger as a partial acquisition.
“Instead of a complete walkaway, Walgreens has now proposed to buy about half of Rite Aid’s stores. If this arrangement is sustained, which Walgreens’ CEO Stefano Pessina believes will be the case, Walgreens will hold a strong position against its principal rival, CVS,” Gordon said.
Subscribers can access the full article here.
Related Insights
April 16, 2026
Manufacturing Industry Advisor
Foley Automotive Update
Foley is here to help you through all aspects of rethinking your long-term business strategies, investments, partnerships, and technology. Contact the authors, your Foley relationship partner, or our Automotive Team to discuss and learn more.
April 16, 2026
Foley Viewpoints
USPTO's AI Search Pilot May Reshape Patent Filing Strategy
The U.S. Patent and Trademark Office's Artificial Intelligence Search Automated Pilot, or ASAP, program introduces earlier visibility into the prior art landscape by providing applicants with an automated search results notice prior to substantive examination.
April 16, 2026
Foley Viewpoints
Delaware Chancery Rejects “Race to the Courthouse” in Enforcing Texas Exclusive Forum Bylaw, Dismissing Three Derivative Lawsuits filed before Tesla’s Redomestication
On April 13, 2026, the Delaware Court of Chancery dismissed three derivative suits in In re Tesla, Inc. Derivative Litigation based on Tesla’s forum selection bylaw requiring that those lawsuits be brought in Texas. All three derivative lawsuits were filed after Tesla announced its proposal to redomesticate and adopt a Texas exclusive forum bylaw but before the redomestication and amended bylaw became effective after shareholder approval.